Business Context and Reporting Period
Company: Mangoceuticals, Inc. (MGRX)
Filing Type: Form 8-K (Current Report)
Date of Report: February 3, 2025 (Events reported through February 6, 2025)
Reporting Period: Specific corporate events occurring in early February 2025.
Key Financial Metrics
This filing does not contain comprehensive financial statements (revenue, profit, cash flow, or margins). The only specific financial data disclosed relates to a private equity transaction:
- Capital Raised: $105,000
- Shares Issued: 70,000 shares of restricted common stock
- Price Per Share: $1.50
- Debt and Liquidity: The filing text does not provide a clear value for total debt or current liquidity positions.
Material Changes
The filing reports two material corporate actions:
- Unregistered Sale of Equity (Item 3.02): On February 3, 2025, the Company sold 70,000 shares to an accredited investor under Section 4(a)(2) and/or Rule 506 of Regulation D. No underwriters were involved.
- Executive Compensation and Role Expansion (Item 5.02): Effective February 6, 2025, the Company amended the employment agreement of Amanda Hammer (Chief Operating Officer). Her role was expanded to include COO of the wholly-owned subsidiary, Mango & Peaches Corp. (M&P). Her annual compensation was increased to $180,000, and she received a $15,000 cash bonus.
Guidance, Outlook, and Risks
Management Commentary: The filing details the expansion of Ms. Hammer's role to support the subsidiary M&P. It notes that the Company agreed to issue Mr. Cohen 1,700,000 shares of M&P common stock (25.4% ownership) and 100 shares of Series A Super Majority Voting Preferred Stock (controlling 51% of total votes on M&P matters).
Risks and Contingencies: The newly issued common stock is subject to transfer restrictions and contains a legend stating it is unregistered and cannot be sold absent registration or an exemption. The filing does not provide forward-looking guidance on revenue or operational targets.
Investor Verification Checklist
- Verify the impact of the $105,000 capital raise on the Company's current cash runway.
- Review the full text of the "Hammer Amendment" (Exhibit 10.2) for additional performance metrics or vesting schedules not summarized here.
- Confirm the governance structure of the subsidiary Mango & Peaches Corp., specifically the voting rights held by Mr. Cohen via the Series A Preferred Stock.
- Check for any subsequent filings regarding the registration status of the 70,000 shares issued to the accredited investor.